Acid Sphingomyelinase Inhibition Prevents Development of Sepsis Sequelae in the Murine Liver-Reference-Cited by-同舟云学术

Acid Sphingomyelinase Inhibition Prevents Development of Sepsis Sequelae in the Murine Liver

Published:2017-09-27 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Chung Ha-Yeun,Witt C. Julius,Jbeily Nayla,Hurtado-Oliveros Jorge,Giszas Benjamin,Lupp Amelie,Gräler Markus H.,Bruns Tony^ORCID,Stallmach Andreas,Gonnert Falk A.,Claus Ralf A.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-11837-2.pdf

Reference57 articles.

1. Engel, C. et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive care medicine 33, 606–618, doi: https://doi.org/10.1007/s00134-006-0517-7 (2007).

2. Gaieski, D. F., Edwards, J. M., Kallan, M. J. & Carr, B. G. Benchmarking the incidence and mortality of severe sepsis in the United States. Critical care medicine 41, 1167–1174, doi: https://doi.org/10.1097/CCM.0b013e31827c09f8 (2013).

3. Gustot, T. Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Current opinion in critical care 17, 153–159, doi: https://doi.org/10.1097/MCC.0b013e328344b446 (2011).

4. Recknagel, P. et al. Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis. PLoS medicine 9, e1001338, doi: https://doi.org/10.1371/journal.pmed.1001338 (2012).

5. Winters, B. D. et al. Long-term mortality and quality of life in sepsis: a systematic review. Critical care medicine 38, 1276–1283, doi: https://doi.org/10.1097/CCM.0b013e3181d8cc1d (2010).

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomal miR-146a-5p Derived from HSCs Accelerates Sepsis-induced Liver Injury by Suppressing KLF-4;2024-07-31

2. Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19;Cells;2023-07-26

3. The relevance of acid sphingomyelinase as a potential target for therapeutic intervention in hepatic disorders: current scenario and anticipated trends;Archives of Toxicology;2023-05-29

4. The Niemann-Pick type diseases – A synopsis of inborn errors in sphingolipid and cholesterol metabolism;Progress in Lipid Research;2023-04

5. Small molecules targeting endolysosomal acidification and signaling in sepsis and severe SARS-CoV-2 infection/COVID-19;Exploration of Immunology;2022-08-11